Posted elsewhere: Billy10us Saturday, 12/16/17
Post# of 72446
(Total Views: 367)
Posted On: 12/17/2017 2:05:50 AM
Posted elsewhere:
Billy10us
Saturday, 12/16/17 09:16:14 PM
Re: None
Post # 208612
Possible B inroads in Europe. I came across an interesting few sentences in an editorial of a medical periodical this weekend. It was in an Austrian paper written in German with a reference to a French physician that specializes in neck and throat cancer who seemingly has followed Ipix trials. Unfortunately after a little research I wasn't able to find the reference, but will keep trying when time permits. What I found so interesting is that Novartis was mentioned in the article as an interested party to the progress of an American company (Ipix not mentioned) in clinical trials of OM. FYI: Novartis is the second largest Global Pharma in the world and its headquarters is in Basel, Switzerland. The new European patent is either very timely or quite coincidental or is it? I just thought I would share this tidbit. I will keep perusing other periodicals. Even though I am fluent in French and German technical medical jargon and terminology is problematic at times for me to interpret. Finally IMHO, B-OM will be a Godsend even in the worst case scenario. If it only is efficacious for 35% of the population and assuming there are 10 million sufferers/year of this affliction. 3.5 million will be cured/helped. What Pharma wouldn't want to have that drug? P will also be a huge benefit to those suffers with significant remuneration with whomever partners with Ipix. Lastly, K is why I invested in CTIX/IPIX 6 years ago. MAKO albeit a reprehensible company has afforded me the ability to make lemonade from lemons as they plummeted the SP. Sorry for the trite metaphor. My DD and medical background tells me that K will be a winner, too. That being said K will probably take more time to reach fruition. I pray mostly that millions of people will be alleviated from the horrible suffering and pain. Additionally, K could very well save millions of lives. To that end I pray that God hears the words from my lips and that it reaches his ears. Making money with Ipix is just a bonus for me. My mother had throat cancer and I watched her suffer unbelievably for 10 years before she passed away. All the best to everyone. Merry Christmas, happy holidays and safe and healthy New Year.
groton68
Saturday, 12/16/17 07:45:26 PM
Re: sox040713 post# 208589
Post # 208595
I spoke to Leo the other day. He told me re: OM. They would have liked results like the preliminary but these results are good for a debilitating OM. The final report will probably take 60 days or so. BP wants to see that report before they would make any move.
Re: K they said they will have an update by year end
re: P. All patients will finish follow up shortly. Then report must be compiled. That takes time
No surprises above. This is all public info.
I don’t believe that based on above there will be any early surprise of a partnership.
Need to be patient
Billy10us
Saturday, 12/16/17 09:16:14 PM
Re: None
Post # 208612
Possible B inroads in Europe. I came across an interesting few sentences in an editorial of a medical periodical this weekend. It was in an Austrian paper written in German with a reference to a French physician that specializes in neck and throat cancer who seemingly has followed Ipix trials. Unfortunately after a little research I wasn't able to find the reference, but will keep trying when time permits. What I found so interesting is that Novartis was mentioned in the article as an interested party to the progress of an American company (Ipix not mentioned) in clinical trials of OM. FYI: Novartis is the second largest Global Pharma in the world and its headquarters is in Basel, Switzerland. The new European patent is either very timely or quite coincidental or is it? I just thought I would share this tidbit. I will keep perusing other periodicals. Even though I am fluent in French and German technical medical jargon and terminology is problematic at times for me to interpret. Finally IMHO, B-OM will be a Godsend even in the worst case scenario. If it only is efficacious for 35% of the population and assuming there are 10 million sufferers/year of this affliction. 3.5 million will be cured/helped. What Pharma wouldn't want to have that drug? P will also be a huge benefit to those suffers with significant remuneration with whomever partners with Ipix. Lastly, K is why I invested in CTIX/IPIX 6 years ago. MAKO albeit a reprehensible company has afforded me the ability to make lemonade from lemons as they plummeted the SP. Sorry for the trite metaphor. My DD and medical background tells me that K will be a winner, too. That being said K will probably take more time to reach fruition. I pray mostly that millions of people will be alleviated from the horrible suffering and pain. Additionally, K could very well save millions of lives. To that end I pray that God hears the words from my lips and that it reaches his ears. Making money with Ipix is just a bonus for me. My mother had throat cancer and I watched her suffer unbelievably for 10 years before she passed away. All the best to everyone. Merry Christmas, happy holidays and safe and healthy New Year.
groton68
Saturday, 12/16/17 07:45:26 PM
Re: sox040713 post# 208589
Post # 208595
I spoke to Leo the other day. He told me re: OM. They would have liked results like the preliminary but these results are good for a debilitating OM. The final report will probably take 60 days or so. BP wants to see that report before they would make any move.
Re: K they said they will have an update by year end
re: P. All patients will finish follow up shortly. Then report must be compiled. That takes time
No surprises above. This is all public info.
I don’t believe that based on above there will be any early surprise of a partnership.
Need to be patient
(4)
(0)Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
